Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    Scleroderma AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Condition: Systemic Sclerosis
Intervention: Drug: Cialis
2 Recruiting Duke Autoimmunity in Pregnancy Registry
Conditions: Pregnancy;   Systemic Lupus Erythematosus;   Cutaneous Lupus;   Rheumatoid Arthritis;   Sjogren's Syndrome;   Scleroderma
Intervention:
3 Not yet recruiting Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Condition: Scleroderma, Systemic
Interventions: Drug: GSK2330811;   Drug: Placebo
4 Completed Study of Silicone-Associated Connective Tissue Diseases
Conditions: Autoimmune Diseases;   Connective Tissue Diseases;   Scleroderma, Circumscribed;   Scleroderma, Systemic
Intervention:
5 Recruiting Pregnancy and Medically Assisted Conception in Rare Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Systemic Lupus Erythematosus;   Antiphospholipid Syndrome;   Sjogren Syndrome;   Scleroderma;   Myositis;   Vasculitis;   Mastocytosis;   Various Autoimmune and/or Systemic and/or Rare Diseases
Intervention:
6 Completed Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome;   Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid;   Scleroderma, Systemic
Intervention: Drug: Ophthalmic Emulsion
7 Terminated Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
Conditions: Coronary Artery Disease;   Inflammatory Response;   Atherosclerosis
Intervention: Dietary Supplement: eicosapentaenoic acid (EPA),
8 Withdrawn Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD
Condition: Gastroesophageal Reflux Disease (GERD)
Intervention: Device: EsophyX™ system with SerosaFuse fasteners
9 Recruiting A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Condition: Scleroderma, Systemic
Interventions: Drug: Nintedanib;   Drug: Placebo
10 Terminated GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
Conditions: Lupus Erythematosus, Systemic;   Systemic Vasculitis;   Isolated Angiitis of Central Nervous System;   Lung Disease With Systemic Sclerosis;   Lung Disease Interstitial Diffuse
Interventions: Drug: depot leuprolide acetate 3.75 mg;   Drug: Placebo
11 Recruiting Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne
Condition: Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Interventions: Combination Product: PDF+M-DDO;   Combination Product: A+PBO

Study has passed its completion date and status has not been verified in more than two years.